Ernica Clinical Consensus Statements on Total Colonic and Intestinal Aganglionosis

Space: StayCurrentMD Author: Anna Löf Granström, Willemijn Irvine, Anders Telle Hoel, Merit Tabbers, Kristiina Kyrklund, Francesco Fascetti-Leon, Fabio Fusaro, Nikhil Thapar, Anne Dariel, Cornelius E.J. Sloots, Marc Miserez, Annette Lemli, Sabine Alexander, Cecile Lambe, Célia Crétol Published:

Author / Expert

Anna Löf Granström, Willemijn Irvine, Anders Telle Hoel, Merit Tabbers, Kristiina Kyrklund, Francesco Fascetti-Leon, Fabio Fusaro, Nikhil Thapar, Anne Dariel, Cornelius E.J. Sloots, Marc Miserez, Annette Lemli, Sabine Alexander, Cecile Lambe, Célia Crétol

Topic overview

Hirschsprung disease is a congenital intestinal motility disorder characterized by an absence of enteric ganglion cells. Total colonic aganglionosis and near total or total intestinal aganglionosis, defined as absence of ganglion cells in the entire colon and with variable length of small bowel involved, are life-threatening conditions which affect less than 10 % of all patients with Hirschsprung disease. The aim of this project was to develop clinical consensus statements within ERNICA, the European Reference Network for rare congenital digestive diseases, on four major topics: Surgical treatment of total colonic aganglionosis, surgical treatment of total intestinal aganglionosis, management of poor bowel function in total colonic and/or intestinal aganglionosis and long-term management in total colonic and or intestinal aganglionosis.

Keywords

Hashtags

0 Views
0 Comments

Comments

Loading comments...